Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph H. Butterfield, Catherine R. Weiler
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 8, pp. 2533-2541
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
Peter Valent, Cem Akin, Bogusław Nedoszytko, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9030-9030
Open Access | Times Cited: 70
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology (2022) Vol. 183, Iss. 7, pp. 693-705
Open Access | Times Cited: 39
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 11, pp. 3918-3928
Open Access | Times Cited: 50
Mast cell activation syndrome and the link with long COVID
Soumya Arun, Abbie Storan, Bethan Myers
British Journal of Hospital Medicine (2022) Vol. 83, Iss. 7, pp. 1-10
Open Access | Times Cited: 33
Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
Joseph H. Butterfield
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2542-2546
Closed Access | Times Cited: 20
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Roberta Parente, Valentina Giudice, Chiara Cardamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7071-7071
Open Access | Times Cited: 17
Using the Right Criteria for MCAS
Theo Gülen
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 39-51
Open Access | Times Cited: 6
Mast cell activation: beyond histamine and tryptase
Theoharis C. Theoharides, Adam Perlman, Assma Twahir, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 639-654
Closed Access | Times Cited: 12
Mast cell activation signature as a potential biomarker in COVID-19
Yatsiri G. Meneses-Preza, Rodolfo Soria-Castro, Ángel R. Alfaro-Doblado, et al.
Immunology Letters (2025), pp. 107026-107026
Closed Access
Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome
Dayne Voelker, Thanai Pongdee
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 33-38
Closed Access | Times Cited: 3
Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?
Cem Akin, Frank Siebenhaar, Joshua B. Wechsler, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1727-1737
Open Access | Times Cited: 3
Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022
Joseph H. Butterfield
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1974-1984
Closed Access | Times Cited: 14
Medical diagnosis based on lattice ordered q-rung linear diophantine fuzzy hypersoft matrices
Surya Annamalai, J. Vimala
Journal of Intelligent & Fuzzy Systems (2024), pp. 1-15
Closed Access | Times Cited: 2
Anaphylaxis: Advances in the Past 10 Years
Catherine R. Weiler, Rik Schrijvers, David B.K. Golden
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 51-62
Closed Access | Times Cited: 10
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference
Jason Gotlib, Tracy I. George, Melody C. Carter, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 147, Iss. 6, pp. 2043-2052
Open Access | Times Cited: 13
Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia
Matthew P. Giannetti, Grace Godwin, Emily Weller, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 5, pp. 1225-1227
Closed Access | Times Cited: 9
The mast cells - Cytokines axis in Autism Spectrum Disorder
Eleonora Kovacheva, Maria Gevezova, Michaël Maes, et al.
Neuropharmacology (2024) Vol. 249, pp. 109890-109890
Open Access | Times Cited: 1
Using differential mobility spectrometry to improve the specificity of targeted measurements of 2,3-dinor 11β-Prostaglandin F2α
Kayla Moehnke, Jennifer Kemp, Michelle R. Campbell, et al.
Clinical Biochemistry (2024) Vol. 126, pp. 110745-110745
Closed Access | Times Cited: 1
Mast cell activation identified through urine mediators
Matthew P. Giannetti, Grace Godwin, Julia Middlesworth, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2531-2533
Closed Access | Times Cited: 1
Treatment of systemic mastocytosis
Matthew P. Giannetti
Annals of Allergy Asthma & Immunology (2021) Vol. 127, Iss. 4, pp. 412-419
Closed Access | Times Cited: 9
Inotodiol suppresses allergic inflammation in allergic rhinitis mice
Jaein Chung, Mira Choi, Soo Kyoung Park, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 9, pp. 1603-1614
Closed Access | Times Cited: 6
Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview
Almudena Matito, María M. Escribese, Natividad Longo, et al.
Journal of Investigational Allergology and Clinical Immunology (2021) Vol. 31, Iss. 6, pp. 461-470
Open Access | Times Cited: 8
Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
Katarina Lyberg, Maria Ekoff, Christine Möller Westerberg, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1909-1911
Open Access | Times Cited: 5
Recent update on the management of anaphylaxis
Quang Luu Quoc, Thi Bich Tra Cao, Jae-Hyuk Jang, et al.
Clinical and Experimental Emergency Medicine (2021) Vol. 8, Iss. 3, pp. 160-172
Open Access | Times Cited: 6
Divergent PGD2 and leukotriene C4 metabolite excretion following aspirin therapy: Ten patients with systemic mastocytosis
Joseph H. Butterfield, Ravinder J. Singh
Prostaglandins & Other Lipid Mediators (2021) Vol. 155, pp. 106563-106563
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top